# Newsight Tech Angels

Newsight Tech Angels is a Private Equity based in Tokyo, Japan.

## Overview

- **Organization type:** Private Equity
- **Headquarters:** Tokyo, Japan
- **Region:** Asia
- **Address:** 2-28-4 Nihonbashi, Chuo-ku, Tokyo, 103-0004, Japan
- **Founded:** 2022
- **Assets under management:** Undisclosed
- **Website:** ntangels.com

## Regulatory record

- **Reports private funds:** No

## About

Newsight Tech Angels is an angel investor group based in Tokyo, Japan, founded in 2022. The group invests in life sciences and financial industries. Newsight Tech Angels has made 10 investments, including a March 24, 2026, investment in Aptadel Therapeutics as part of their Bridge.

## Sectors

- Digital Health
- Healthcare Services

## People

- Toru Seo — Representative Director

## Questions

### Who runs investment decisions at Newsight Tech Angels?

Toru Seo serves as Representative Director and leads the firm, which operates with a team of life-science and finance professionals. The firm has not disclosed a separate investment committee or additional named investment partners beyond Seo.

### Does Newsight Tech Angels invest only in US companies?

While the firm uses a Delaware LLC to source US deals, it also invests in Japanese startups — its July 2023 investment in CrestecBio, a University of Tsukuba spinout, confirms domestic Japanese biotech exposure alongside US positions such as GigaMune and TRIO Pharmaceuticals.

## Related profiles

- [New Science Ventures](https://altss.com/profile/new-science-ventures)
- [New Silk Route Growth Capital](https://altss.com/profile/new-silk-route-growth-capital)

---

Last updated: 2026-06-03T20:00:00.000Z

Canonical page: https://altss.com/profile/newsight-tech-angels

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology